Home > Search Results

Results: 9

Five‐alpha‐reductase inhibitor drugs, such as finasteride or dutasteride, reduce the risk prostate cancer in men who have routine prostate cancer screening

Five‐alpha‐reductase inhibitor drugs have potential as chemopreventive agents. Reduction of prostate cancer was similar between racial groups, age groups (aged 65 years or older compared to younger age groups) and those with or without a family history of prostate cancer. Reduction of prostate cancer was limited to men who had a baseline prostate specific antigen (PSA) values less than 4.0 ng/mL. However, use of five‐alpha‐reductase inhibitors may also increase the risk of high‐grade prostate cancer in men undergoing prostate cancer screening. Future research is needed to determine if the use of five‐alpha‐reductase inhibitors can reduce prostate cancer in men who are not being regularly screened for prostate cancer. Future studies should also determine whether five‐alpha‐reductase inhibitors can reduce death and prostate cancer death and further evaluate the risk of developing high‐grade prostate cancer.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2012

Finasteride provides relief of symptoms related to benign prostatic hyperplasia.

Finasteride, when compared to placebo and active comparators, improves long‐term urinary tract symptoms associated with benign prostatic hyperplasia.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2016

Benign enlarged prostate: Medication and herbal products

Most men who have prostate problems either wait a while to see how their symptoms develop, or take medication. Medication is often used when the symptoms are not bad enough for surgery to be needed, but have become too bothersome to be left untreated.This might be the case if you have to go to the bathroom several times a night, or constantly feel the need to urinate during the day too because your bladder no longer empties properly. These typical symptoms of an enlarged prostate can become a real burden.Several types of medications and combinations of medications are available for the relief of problems associated with an enlarged prostate. Like with any medication, it is important to carefully consider the advantages and disadvantages of these medications, and be aware of possible interactions between different medications. The majority of men with an enlarged prostate are over the age of 50, and often on other medications too, like drugs for high blood pressure (hypertension).For instance, if a man is taking alpha blockers for the treatment of prostate problems, he should not use impotence drugs as well. This is because both of these medications have a blood-pressure-lowering effect, so his blood pressure could become too low otherwise.

Informed Health Online [Internet] - Institute for Quality and Efficiency in Health Care (IQWiG).

Version: January 15, 2014

Treatments for female pattern hair loss

The most common type of hair loss in women is FPHL, also known as androgenic alopecia. Unlike men, women do not go bald, but have hair thinning predominantly over the top and front of the head. It can occur at any time, from puberty until later in life. However, it occurs more frequently in postmenopausal women.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2016

Treatments for unwanted male pattern hair growth in women

Up to 5% to 10% of women are hirsute (hair in areas where normally only men have hairs such as moustache, beard area, chest, belly, back etc). The most common cause is polycystic ovary syndrome. Hirsutism can lead to psychological distress, low self esteem, decreased self image, depression, feelings of shame and social difficulties.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2015

Prostate Cancer Prevention (PDQ®): Patient Version

Expert-reviewed information summary about factors that may influence the risk of developing prostate cancer and about research aimed at the prevention of this disease.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: September 8, 2016

Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne

The evidence suggests a lack of evidence to show whether spironolactone can reduce hirsutism and acne. Hirsutism in women (excessive hair growth) is most often caused by an increased production of male hormones. Spironolactone (`Aldactone' or `Spirotone') is an anti‐androgen, which can be taken with or without the oral contraceptive pill to try and reduce hirsutism. From the studies included in this review, there is some evidence to show that spironolactone is an effective treatment to decrease the degree of hirsutism, but insufficient evidence for the management of acne vulgaris. It appears to be more effective than finasteride 5mg/day, metformin and low dose cyproterone acetate.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2011

Cyproterone acetate appears to be as effective as other medications for hirsutism in women caused by excessive androgen production by the ovaries

One of the causes of hirsutism (excessive hair growth) in women is excessive production of the hormone androgens by the ovaries. A variety of medications can be used to counter the effects of the androgen. Cyproterone acetate is an anti‐androgen drug. Adverse effects that have been reported with its use include weight gain, depression, fatigue, breast symptoms and sexual dysfunction. The review of trials found that cyproterone acetate appears to have a similar impact on hirsutism as other drugs used for hirsutism caused by excessive androgen. There was not enough evidence to compare adverse effects of the treatment options.

Cochrane Database of Systematic Reviews: Plain Language Summaries [Internet] - John Wiley & Sons, Ltd.

Version: 2009

Cancer Prevention Overview (PDQ®): Patient Version

General information about cancer prevention and descriptions of the concepts used in cancer-specific prevention summaries.

PDQ Cancer Information Summaries [Internet] - National Cancer Institute (US).

Version: February 23, 2017

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...